APOE Genotype (Alzheimer's Risk)
Tests Apolipoprotein E E2/E3/E4 variants, determines genetic Alzheimer's risk and eligibility for new anti-amyloid therapies (lecanemab). One-time lifetime test. 2-week turnaround.
What’s measured
1 biomarker in this panel, from a single sample.
- APOE Genotype (Alzheimer's risk)
A single clinic blood draw by a nurse
Questions
How long do results take?+
Most results are reviewed and released within a few days of the lab receiving your sample — typically 10+ working days. Genetic and specialist panels take longer; your exact turnaround is confirmed when you order.
Can I choose a home kit or a clinic?+
This test is a clinic blood draw, as it needs a venous sample for accuracy. We arrange a convenient appointment for you.
Is a doctor involved?+
Yes. Every result is reviewed by a GMC-registered doctor who signs it off and explains what it means and what to do next. This is never a results-only service.
Is it confidential?+
Completely. Your sample is analysed at a UKAS-accredited (ISO 15189) laboratory, your results are private to your secure portal, and your data is never shared without your consent.